Metraipolis › archive › dc_bc47c7b83ff0

Efficacy of Disitamab Vedotin in Treating HER2 2+/FISH-Bladder Cancer: A Case Report — Europe PMC PMID:42339139

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42339139
DOI
10.1002/ccr3.72855
License (as archived)
solo-consultazione
Archived
2026-10-19T07:16:43.591Z
SHA-256 of the archived text
13da512cc4c81aded15b49d415d787f6533c2e6c090d5ff0384bbdb0909cd2cd
Stable URL of this page
https://metraipolis.com/documento/dc_bc47c7b83ff0

How to cite

Efficacy of Disitamab Vedotin in Treating HER2 2+/FISH-Bladder Cancer: A Case Report — Europe PMC PMID:42339139 — Europe PMC (en), https://europepmc.org/article/MED/42339139 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bc47c7b83ff0 (Metraipolis archive dc_bc47c7b83ff0, sha256 13da512cc4c81aded15b49d415d787f6533c2e6c090d5ff0384bbdb0909cd2cd)
BibTeX
@misc{dcbc47c7b83ff0,
  title = {Efficacy of Disitamab Vedotin in Treating HER2 2+/FISH-Bladder Cancer: A Case Report — Europe PMC PMID:42339139},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42339139},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bc47c7b83ff0; sha256 13da512cc4c81aded15b49d415d787f6533c2e6c090d5ff0384bbdb0909cd2cd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42339139. Agents can read the archived copy with the MCP tool read_document.